Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of MEDI-507 in the Treatment of Adult Patients With at Least Grade II Steroid-Resistant Acute Graft-Versus-Host Disease

NCT00806728 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00806728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00806728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of MEDI-507 in the Treatment of Adult Patients With at Least Grade II Steroid-Resistant Acute Graft-Versus-Host Disease
Lead sponsor
MedImmune LLC
Phase
Phase 1
Overall status
Completed
Start date
May 31, 1998
Completion date
December 31, 1998
Enrollment
17 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, graft-versus-host disease